Sapporo Clinical Laboratory Balance Sheet Health
Financial Health criteria checks 5/6
Sapporo Clinical Laboratory has a total shareholder equity of ¥11.1B and total debt of ¥1.6B, which brings its debt-to-equity ratio to 14.7%. Its total assets and total liabilities are ¥16.9B and ¥5.8B respectively. Sapporo Clinical Laboratory's EBIT is ¥610.0M making its interest coverage ratio 305. It has cash and short-term investments of ¥4.0B.
Key information
14.7%
Debt to equity ratio
JP¥1.63b
Debt
| Interest coverage ratio | 305x |
| Cash | JP¥3.99b |
| Equity | JP¥11.10b |
| Total liabilities | JP¥5.84b |
| Total assets | JP¥16.94b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 9776's short term assets (¥7.9B) exceed its short term liabilities (¥3.6B).
Long Term Liabilities: 9776's short term assets (¥7.9B) exceed its long term liabilities (¥2.2B).
Debt to Equity History and Analysis
Debt Level: 9776 has more cash than its total debt.
Reducing Debt: 9776's debt to equity ratio has increased from 0% to 14.7% over the past 5 years.
Debt Coverage: 9776's debt is well covered by operating cash flow (95.9%).
Interest Coverage: 9776's interest payments on its debt are well covered by EBIT (305x coverage).